122 related articles for article (PubMed ID: 31697927)
41. Combinatorial Effects of the Glucocorticoid Receptor and Krüppel-Like Transcription Factor 15 on Bovine Herpesvirus 1 Transcription and Productive Infection.
El-Mayet FS; Sawant L; Thunuguntla P; Jones C
J Virol; 2017 Nov; 91(21):. PubMed ID: 28794031
[TBL] [Abstract][Full Text] [Related]
42. Hypertensive nephropathy. Moving from classic to emerging pathogenetic mechanisms.
Seccia TM; Caroccia B; Calò LA
J Hypertens; 2017 Feb; 35(2):205-212. PubMed ID: 27782909
[TBL] [Abstract][Full Text] [Related]
43. The Key Role of Epithelial to Mesenchymal Transition (EMT) in Hypertensive Kidney Disease.
Seccia TM; Caroccia B; Piazza M; Rossi GP
Int J Mol Sci; 2019 Jul; 20(14):. PubMed ID: 31330886
[TBL] [Abstract][Full Text] [Related]
44. Angiotensin II provokes podocyte injury in murine model of HIV-associated nephropathy.
Ideura H; Hiromura K; Hiramatsu N; Shigehara T; Takeuchi S; Tomioka M; Sakairi T; Yamashita S; Maeshima A; Kaneko Y; Kuroiwa T; Kopp JB; Nojima Y
Am J Physiol Renal Physiol; 2007 Oct; 293(4):F1214-21. PubMed ID: 17652372
[TBL] [Abstract][Full Text] [Related]
45. A KDM6A-KLF10 reinforcing feedback mechanism aggravates diabetic podocyte dysfunction.
Lin CL; Hsu YC; Huang YT; Shih YH; Wang CJ; Chiang WC; Chang PJ
EMBO Mol Med; 2019 May; 11(5):. PubMed ID: 30948420
[TBL] [Abstract][Full Text] [Related]
46. Podocyte loss involves MDM2-driven mitotic catastrophe.
Mulay SR; Thomasova D; Ryu M; Kulkarni OP; Migliorini A; Bruns H; Gröbmayr R; Lazzeri E; Lasagni L; Liapis H; Romagnani P; Anders HJ
J Pathol; 2013 Jul; 230(3):322-35. PubMed ID: 23749457
[TBL] [Abstract][Full Text] [Related]
47. Rho-kinase inhibition prevents proteinuria in immune-complex-mediated antipodocyte nephritis.
Meyer-Schwesinger C; Dehde S; Sachs M; Mathey S; Arefi K; Gatzemeier S; Balabanov S; Becker JU; Thaiss F; Meyer TN
Am J Physiol Renal Physiol; 2012 Oct; 303(7):F1015-25. PubMed ID: 22811486
[TBL] [Abstract][Full Text] [Related]
48. Smad3/Nox4-mediated mitochondrial dysfunction plays a crucial role in puromycin aminonucleoside-induced podocyte damage.
Yu L; Liu Y; Wu Y; Liu Q; Feng J; Gu X; Xiong Y; Fan Q; Ye J
Cell Signal; 2014 Dec; 26(12):2979-91. PubMed ID: 25229402
[TBL] [Abstract][Full Text] [Related]
49. KLF15 Regulates the Expression of MMP-3 in Human Chondrocytes.
Li Y; Zhao M; Xiao W
J Interferon Cytokine Res; 2018 Aug; 38(8):356-362. PubMed ID: 30036111
[TBL] [Abstract][Full Text] [Related]
50. Low-protein diet supplemented with ketoacids reduces the severity of renal disease in 5/6 nephrectomized rats: a role for KLF15.
Gao X; Huang L; Grosjean F; Esposito V; Wu J; Fu L; Hu H; Tan J; He C; Gray S; Jain MK; Zheng F; Mei C
Kidney Int; 2011 May; 79(9):987-96. PubMed ID: 21248717
[TBL] [Abstract][Full Text] [Related]
51. Metabolic rewiring of the hypertensive kidney.
Rinschen MM; Palygin O; Guijas C; Palermo A; Palacio-Escat N; Domingo-Almenara X; Montenegro-Burke R; Saez-Rodriguez J; Staruschenko A; Siuzdak G
Sci Signal; 2019 Dec; 12(611):. PubMed ID: 31822592
[TBL] [Abstract][Full Text] [Related]
52. Angiotensin II Type I Receptor Agonistic Autoantibody Induces Podocyte Injury via Activation of the TRPC6- Calcium/Calcineurin Pathway in Pre-Eclampsia.
Yu Y; Zhang L; Xu G; Wu Z; Li Q; Gu Y; Niu J
Kidney Blood Press Res; 2018; 43(5):1666-1676. PubMed ID: 30380548
[TBL] [Abstract][Full Text] [Related]
53. Kruppel-like factor 15 is a regulator of cardiomyocyte hypertrophy.
Fisch S; Gray S; Heymans S; Haldar SM; Wang B; Pfister O; Cui L; Kumar A; Lin Z; Sen-Banerjee S; Das H; Petersen CA; Mende U; Burleigh BA; Zhu Y; Pinto YM; Liao R; Jain MK
Proc Natl Acad Sci U S A; 2007 Apr; 104(17):7074-9. PubMed ID: 17438289
[TBL] [Abstract][Full Text] [Related]
54. The research status and prospect of Periostin in chronic kidney disease.
Jia YY; Yu Y; Li HJ
Ren Fail; 2020 Nov; 42(1):1166-1172. PubMed ID: 33241962
[TBL] [Abstract][Full Text] [Related]
55. KLF15-Cyp3a11 Axis Regulates Rifampicin-Induced Liver Injury.
Hou W; Huo KG; Guo X; Xu M; Yang Y; Shi Z; Xu W; Tu J; Gao T; Ma Z; Han S
Drug Metab Dispos; 2024 Jun; 52(7):606-613. PubMed ID: 38670799
[TBL] [Abstract][Full Text] [Related]
56. Protective effect of KLF15 on vascular endothelial dysfunction induced by TNF‑α.
Liu B; Xu L; Yu X; Li W; Sun X; Xiao S; Guo M; Wang H
Mol Med Rep; 2018 Aug; 18(2):1987-1994. PubMed ID: 29956764
[TBL] [Abstract][Full Text] [Related]
57. Late angiotensin II receptor blockade in progressive rat mesangioproliferative glomerulonephritis: new insights into mechanisms.
Villa L; Boor P; Konieczny A; Kunter U; van Roeyen CR; Denecke B; Gan L; Neusser MA; Cohen CD; ; Eitner F; Scholl T; Ostendorf T; Floege J
J Pathol; 2013 Apr; 229(5):672-84. PubMed ID: 23192593
[TBL] [Abstract][Full Text] [Related]
58. Critical roles of PI3K/Akt/NF‑κB survival axis in angiotensin II‑induced podocyte injury.
Wang J; Fu D; Senouthai S; You Y
Mol Med Rep; 2019 Dec; 20(6):5134-5144. PubMed ID: 31638199
[TBL] [Abstract][Full Text] [Related]
59. Smad3 mediates ANG II-induced hypertensive kidney disease in mice.
Liu Z; Huang XR; Lan HY
Am J Physiol Renal Physiol; 2012 Apr; 302(8):F986-97. PubMed ID: 22237801
[TBL] [Abstract][Full Text] [Related]
60. Shp2 Associates with and Enhances Nephrin Tyrosine Phosphorylation and Is Necessary for Foot Process Spreading in Mouse Models of Podocyte Injury.
Verma R; Venkatareddy M; Kalinowski A; Patel SR; Salant DJ; Garg P
Mol Cell Biol; 2016 Feb; 36(4):596-614. PubMed ID: 26644409
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]